HRT Without Hot Flashes: Can You Get It, and Will It Help?

When HRT without hot flashes makes sense — and when it doesn't

HRT without hot flashes has the strongest support for treating vaginal symptoms, reducing repeat-UTI risk in suitable women, confirmed early loss of ovarian function, and selected bone-protection needs. Sleep, mood and joint aches need a more specific assessment; evidence for one doesn't establish that all will respond. Brain fog alone and routine heart or dementia prevention after usual-age menopause aren't established reasons to start.

First, a quick word on terms. Doctors call hot flashes and night sweats vasomotor symptoms, or VMS. "Vaso" means blood vessels and "motor" means movement — during a hot flash, blood vessels near your skin open wide to dump heat. Up to 80% of women have VMS at some point during the menopause transition, according to the long-running SWAN study. That leaves a lot of women who don't — and they still go through menopause.

HRT (hormone replacement therapy, also called menopausal hormone therapy) usually means estrogen, plus a progestogen if you still have a uterus. It comes in two broad kinds:

• Systemic HRT — pills, patches, gels and sprays that send estrogen through your whole body.
• Local (vaginal) estrogen — a low-dose cream, tablet or ring that works mainly on vaginal and nearby urinary tissue.

That split matters a lot when you don't have hot flashes. Some of your best options may not be "whole-body HRT" at all. Menopause-related vaginal and urinary changes are called genitourinary syndrome of menopause (GSM).

The No-Hot-Flash Evidence Map

We read the guidelines and trials and sorted the common reasons a woman without hot flashes asks about HRT. Find the row closest to your main concern. The middle column is our editorial reading of the evidence — not a medical grade or an eligibility rule. Your own history still decides. Use the last column at your appointment; don't use this table to pick a drug or dose.

On a small screen, scroll sideways to see every column.

Your main concern (no hot flashes)	Our evidence read	Kind usually discussed	What the evidence says	A question to bring to care
Vaginal dryness, burning or pain with sex	Strong — a main approved use	Low-dose vaginal estrogen first; systemic HRT also treats it	The Menopause Society calls hormone therapy the most effective treatment for these genitourinary symptoms. When they're your only symptoms and nonprescription measures aren't enough, low-dose vaginal estrogen (or vaginal DHEA or ospemifene) may be appropriate. 2022, 2020	"Could local treatment handle this without whole-body HRT?"
Repeat UTIs after menopause	Supported for reducing recurrence — after the cause is checked	Low-dose vaginal estrogen	Vaginal estrogen can reduce future UTIs in suitable peri- and postmenopausal women with recurrent infections. It does not treat a current infection. Menopause Society, AUA GSM guideline	"Is this an infection, menopause-related tissue change, or something else?"
Urinary urgency	Individual assessment — not the same evidence as repeat-UTI prevention	Treatment of the cause; vaginal estrogen may be discussed when GSM is present	Urgency can have several causes. Local estrogen may be considered with GSM and an overactive bladder, but repeat-UTI evidence does not prove that all urgency responds. AUA GSM guideline	"Is this GSM, overactive bladder, an infection, or another problem?"
Night sweats, but no daytime hot flashes	Strong — night sweats are VMS	Systemic HRT	Menopause-related night sweats are VMS too; not all sweating at night is caused by menopause. Hormone therapy is the most effective treatment for VMS. Menopause Society	"Could my night sweats be menopause-related, and what else should be checked?"
Confirmed premature ovarian insufficiency (POI), early menopause, or both ovaries removed before the usual menopause age	Strong for confirmed early hormone loss — often advised even without symptoms	Systemic HRT	The international POI guideline recommends hormone therapy until the usual menopause age even without symptoms, unless contraindicated. Periods stopping early need diagnosis first; the POI recommendation is not a rule for any-age ovary removal. ESHRE/ASRM/IMS	"Does my diagnosis change the purpose and length of hormone treatment?"
High risk of bone loss, under 60 or within 10 years of your last period	Approved use — rarely first choice when bones are the only reason	Systemic HRT	Hormone therapy prevents bone loss and fracture. Labels say that when it's used only for prevention, it's for women at significant risk, and non-estrogen medicines should be considered first. Label	"Why HRT rather than a bone-specific option in my case?"
Trouble sleeping, with no night sweats	Mixed	Systemic HRT, with uterine-lining protection when needed	One trial found HRT helped sleep only in women with frequent hot flashes. Another found sleep improved even after accounting for hot-flash bother. Details below	"What points to a hormone cause, and would CBT-I help?"
Low mood that began with other perimenopause changes	Possible add-on, not first-line for depression	Systemic estrogen	Talk therapy and antidepressants are front-line for perimenopausal depression. Estrogen isn't approved for depression but has shown antidepressant effects in perimenopause, especially with hot flashes. 2018 guidelines	"Is this menopause-related low mood, depression, or both?"
Anxiety or irritability	Limited when hot flashes are absent	Systemic HRT	In the Helsinki trial, anxiety/fear questionnaire scores improved with HRT only in the group with baseline hot flashes. Primary abstract	"What else could be driving this, and how would we measure change?"
Brain fog or forgetting words	Not shown	—	In the Helsinki trial, memory/concentration questionnaire scores improved only in women with baseline hot flashes. That is not proof of treating cognitive impairment. The Menopause Society does not recommend HRT to prevent or treat cognitive decline. Primary abstract, guidance	"What else could explain this, and what would count as improvement?"
Achy joints and muscles	Modest	Systemic estrogen	In the Women's Health Initiative estrogen-only arm, joint pain was slightly less common on estrogen at one year. WHI analysis	"Could arthritis or something else be part of this?"
Low sex drive, without dryness or pain	Indirect	Depends on the cause	Estrogen helps when pain or dryness is the reason desire dropped. Low desire on its own is a different problem; use of an FDA-approved male testosterone product for a woman is off-label in the U.S.; compounded testosterone is not FDA-approved	"Is pain, a medicine, mood or something else affecting desire?"
Fatigue, weight gain or thinning hair alone	Not established	—	These are not established stand-alone indications for HRT. HRT is not a weight-loss treatment; other causes deserve assessment. Menopause Society	"What else should we check first?"
"I feel fine — I want HRT to protect my heart, brain or bones"	Not recommended for routine chronic-disease prevention after usual-age menopause	—	USPSTF recommends against systemic HRT for primary prevention in asymptomatic postmenopausal people. That recommendation excludes POI and surgical menopause; selected osteoporosis prevention is a separate indication. HRT is not approved to prevent heart disease or dementia. USPSTF, label	"Do I have a specific reason for treatment, or is this general prevention?"

Source: The Menopause Society 2022 and 2020 position statements; ESHRE/ASRM/IMS 2024 POI guideline; Maki et al. 2018; USPSTF 2022; Savolainen-Peltonen et al. (Helsinki trial); Geiger et al. 2019; Chlebowski et al. 2013; estradiol prescribing information. Checked October 14, 2026.

The pattern is easy to miss but really useful. The strength of the case comes from evidence for the specific problem — not simply from estrogen acting on that tissue. Vaginal symptoms, recurrent UTIs and bone protection have defined treatment roles. Tiredness, fog and low mood have several possible causes, so the treatment question needs a closer look.

Your situation decides the next step

The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.

It starts with "What brings you here?", and hot flashes are only one of the choices. You can pick trouble sleeping, mood changes, brain fog, low sex drive, vaginal dryness — or "exploring options, with no symptoms right now." Then it asks what you've tried, your age, your state and your health history. It's free, takes about 60 seconds, and doesn't ask for your email. It isn't a medical test, and it doesn't decide whether HRT is right for you — a clinician does.

---

Can you be in perimenopause without hot flashes?

Yes. Hot flashes are common, but they aren't a pass-or-fail test for menopause. A clinician looks at your age, your period pattern, your other symptoms, your medicines and your health history.

A few definitions help:

• Perimenopause is the transition leading up to your last period and through the following 12 months. Periods often become irregular — closer together, further apart, heavier or lighter. It can last for years.
• Menopause is usually confirmed after 12 months in a row with no period, when nothing else explains it.
• Postmenopause is everything after that.

You don't have to wait for that 12-month mark to ask for help with symptoms. "When is menopause confirmed?" and "When can I ask for treatment?" are two different questions.

Do you need a hormone blood test to prove it?

Often not for an otherwise healthy person aged 45 or older with a typical menopause history. Hormone levels swing in perimenopause, so one result can mislead. Without hot flashes, a clinician still needs to assess the period changes and other symptoms; no test is automatically required or ruled out. Testing may be useful under 45 or to check another cause. For more, see do you need blood tests for HRT?

Could it be something else?

It might be. Tiredness, low mood, poor sleep and trouble focusing have many possible causes, and they don't all come from hormones. A good clinician checks the bigger picture before putting everything down to menopause. Hormonal birth control can also mask period changes, so mention it.

Here's what that can look like. (This is a made-up example, not a real patient.) Dana is 47. Her periods now come every three to six weeks. She wakes at 3 a.m. most nights and feels stiff in the morning. She has never had a hot flash. Her age and cycle changes can fit perimenopause, even without hot flashes. A clinician still needs to consider other causes. Her next step is a conversation about which of those problems matters most, not a lab panel she buys herself.

If someone told you "no hot flashes, so it's not menopause," that's not how the transition is recognized. For a fuller list of what to track, see our perimenopause symptoms checklist.

---

What does research say about HRT when you don't have hot flashes?

The Helsinki trial found improvements in sleep, memory/concentration and anxiety/fear scores in women with baseline hot flashes, but no detectable quality-of-life benefit over placebo in women without troublesome baseline flashes. Other trials show smaller, specific benefits, including better sleep that wasn't fully explained by fewer hot flashes. Taken together, the evidence says: don't expect a general lift, but specific problems may still respond.

We picked the four studies that speak most directly to women without hot flashes. They don't all point the same way, and that's the honest picture.

On a small screen, scroll sideways to see every column.

Study	Who took part	What they compared	What it found for the no-hot-flash question	What it means for you
Helsinki trial (Savolainen-Peltonen and colleagues, Menopause 2014; online report 2013)	150 healthy, recently postmenopausal women: 72 classified with hot flashes and 78 without	Estradiol by mouth or through the skin, with or without medroxyprogesterone acetate, vs placebo, for 6 months	No detectable quality-of-life benefit over placebo in women without troublesome baseline flashes. Sleep, memory/concentration and anxiety/fear questionnaire scores improved in the group with baseline hot flashes. Primary abstract	A direct, small six-month study of self-reported well-being — not proof that no individual symptom can improve or that HRT treats cognitive impairment.
Sleep trial (Geiger and colleagues, Menopause 2019)	172 healthy women aged 45–60 in early or late perimenopause or within a year of their last period; hot flashes weren't an entry requirement	Estradiol patch plus intermittent progesterone vs placebo, 12 months	Women on hormones reported falling asleep faster and waking less. The benefit held after accounting for changes in hot-flash bother and depressive symptoms. Study	Sleep may improve for reasons beyond hot flashes. It wasn't a no-hot-flash-only group, and sleep was self-reported.
WISDOM (BMJ 2008)	Women aged 50–69, mostly years past menopause; about 30% had hot flashes at the start	Estrogen plus progestin vs placebo, 1 year	Small improvements in sleep, sexual function and hot flashes; fewer aching joints and less vaginal dryness. No difference in depression or overall quality of life. Study	Small, specific gains are possible in a mixed group.
Women's Health Initiative, estrogen-only arm (Menopause 2013)	10,739 women aged 50–79 who'd had a hysterectomy	Oral conjugated estrogen vs placebo	Joint pain at 1 year: 76.3% on estrogen vs 79.2% on placebo; the gap persisted at year 3 in the smaller follow-up sample. Joint swelling was slightly more common on estrogen (42.1% vs 39.7%). Analysis	A modest, real effect on aches — in older women, with an older type of estrogen.

Source: Sources linked in the table. Checked October 14, 2026 through primary study text or abstracts. The Helsinki paper was published in July 2014; the result summarized here was checked against its primary abstract, not the full paper.

Three takeaways:

1. Overall quality of life: don't count on HRT to lift it if you don't have hot flashes. The Helsinki result concerns its particular population and six-month comparison.
2. Specific symptoms: sleep and aches may still improve modestly, and the reasons may go beyond hot flashes.
3. The practical move: pick one or two problems that matter most, write down where they stand before any treatment agreed with your clinician, and check again at about 4 and 12 weeks or the review dates your clinician sets. We built a tracker for exactly that.

---

Which symptoms can HRT help if you don't have hot flashes?

Vaginal symptoms and recurrent-UTI prevention have well-supported roles for low-dose vaginal estrogen in suitable women. Sleep and achy joints may improve with systemic HRT in some situations, and perimenopausal mood symptoms deserve a separate discussion; HRT isn't first-line treatment for depression. Brain fog, fatigue, weight gain and hair changes alone are not established indications.

Vaginal dryness, painful sex and urinary symptoms

This is the strongest "yes." Doctors call it genitourinary syndrome of menopause (GSM) — dryness, burning, irritation, pain with sex, urgency and repeat UTIs caused by lower estrogen in vaginal and bladder tissue. It affects roughly 27% to 84% of postmenopausal women, and The Menopause Society says it's likely underdiagnosed and undertreated. Source

Three things make GSM different from other symptoms:

• It doesn't need hot flashes. Plenty of women have GSM and never flush.
• It tends to get worse, not better, without treatment. UChicago Medicine notes that hot flashes ease over time, but vaginal symptoms worsen if untreated. Source
• The usual treatment is local, not whole-body. Low-dose vaginal estrogen works right where the problem is. The Menopause Society says a progestogen isn't needed with low-dose vaginal estrogen, though trials haven't studied uterine-lining safety beyond one year. Source

Over-the-counter lubricants and moisturizers come first for mild symptoms. If they're not enough, prescription options include low-dose vaginal estrogen, vaginal DHEA and ospemifene. You can use vaginal estrogen alongside whole-body HRT if you need both.

With repeat UTIs, one caution: a current infection still needs its own diagnosis and treatment. Vaginal estrogen is about lowering future risk, not treating today's infection. Clinical guidance. More on this in HRT and recurrent UTIs.

If vaginal or urinary symptoms are your only concern, read how local vaginal estrogen differs from systemic HRT before you choose care. For prices, see the cheapest vaginal estrogen without insurance.

Sleep problems without night sweats

The evidence is mixed. In the Helsinki trial, sleep questionnaire scores improved with HRT only in women with baseline hot flashes. But in a 12-month trial of 172 women, an estradiol patch plus progesterone improved how fast women fell asleep and how often they woke — and that benefit held after accounting for changes in hot-flash bother and mood. Study

So HRT may help some women sleep better for reasons beyond hot flashes. It isn't a proven insomnia treatment for everyone.

Two more things worth knowing:

• Progesterone's job in HRT is protecting the uterus lining. It can make some women drowsy, which is why it's often taken at bedtime — but "it helps me sleep" isn't, on its own, a reason to choose a regimen. More in does progesterone help sleep in menopause?
• Long-term insomnia has its own first-line treatment. CBT-I (cognitive behavioral therapy for insomnia) is a structured program that changes sleep habits and thoughts that keep insomnia going. The National Heart, Lung, and Blood Institute describes it as a usual first treatment for long-term insomnia. NHLBI

A reasonable approach is to ask about both. For more, see menopause sleep problems and treatment options.

Low mood, anxiety and irritability

For perimenopausal depression, the 2018 guidelines from The North American Menopause Society and a depression-center task force name antidepressants and talk therapy as front-line treatment. Estrogen isn't approved to treat depression, but it has shown antidepressant effects in perimenopausal women, particularly those who also have hot flashes. The same guidelines say estrogen isn't effective for depressive disorders after menopause. Guidelines

UK guidance goes a step further for milder symptoms. NICE says clinicians can consider HRT for depressive symptoms that don't meet the criteria for depression and that started around the same time as other menopause symptoms. That's UK guidance, not a U.S. rule — but it reflects the same idea: timing and pattern matter. NICE NG23

For anxiety on its own, the evidence is thinner. In the Helsinki trial, anxiety/fear questionnaire scores improved with HRT only in the group with baseline hot flashes.

If you're having thoughts of harming yourself, call or text 988 (U.S.) now. For care options, see menopause, low mood and anxiety and online menopause care for anxiety and mood swings.

Brain fog and memory

HRT hasn't been established as a stand-alone treatment for brain fog. In the Helsinki trial, self-reported memory/concentration improved only in the group with baseline hot flashes; that isn't a test of treating cognitive impairment. The Menopause Society doesn't recommend hormone therapy to prevent or treat cognitive decline. Primary abstract · Guidance

That's frustrating if fog is your biggest problem, and we don't want to wave it away. Poor sleep and low mood can both make thinking harder. Sometimes fog lifts when one of those gets treated. That's different from HRT treating fog directly.

So, is HRT worth it if brain fog and fatigue are your only symptoms? Based on current evidence, probably not as a first step. Ask a clinician to look at sleep, mood, medicines and other causes. If fog is getting worse or affecting daily life, that deserves its own assessment. More in HRT and brain fog.

Achy joints and muscles

Small but real. In a post-hoc analysis of the Women's Health Initiative estrogen-only arm, 76.3% of women on estrogen reported joint pain at one year, vs 79.2% on placebo, and that difference persisted in the smaller sample assessed at year three. Joint swelling, though, was slightly more common on estrogen. These were women aged 50 to 79 on an older oral estrogen, so modern regimens may differ. Analysis

Aches have lots of causes, including arthritis. If yours are new, swollen or getting worse, mention that. More in HRT and joint pain.

Low sex drive

It depends on why. If dryness or pain makes sex unappealing, treating GSM can help a lot. If desire itself has dropped without pain, that's a different problem with different causes — relationship, mood, medicines, stress and more.

Testosterone sometimes comes up here. The 2019 Global Consensus supports it for postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD) — low desire causing distress — after an assessment of medical, emotional and relationship factors. It isn't a general treatment for energy, mood or brain fog. In the U.S., there's no FDA-approved testosterone product for menopausal low desire. Using an approved male formulation for that purpose is off-label; compounded testosterone is a different, non-FDA-approved product. Testosterone is a prescription Schedule III controlled substance and needs clinician monitoring. Consensus · DEA. More in testosterone for menopause and online care for low libido.

Fatigue, weight gain and thinning hair

None of these is an established stand-alone indication for HRT. Even Gala, our featured partner, says on its own FAQ that HRT isn't a weight-loss medicine. Ask what else could be going on. See does HRT cause weight gain?

---

Vaginal estrogen or whole-body HRT: which fits your symptoms?

If your only symptoms are vaginal or urinary, ask whether GSM is the cause. Mild vaginal symptoms may respond to moisturizers or lubricants; low-dose vaginal estrogen is an effective prescription option and generally doesn't need a progestogen. Systemic HRT needs a specific treatment purpose and uterine-lining protection when you still have a uterus.

On a small screen, scroll sideways to see every column.

	Low-dose vaginal estrogen (local)	Systemic estrogen (pill, patch, gel, spray, systemic ring)	A progestogen (with systemic estrogen)	Non-hormonal care
Main job here	Vaginal dryness, painful sex and selected urinary symptoms, including repeat-UTI prevention	Appropriate systemic indications, including VMS, early hormone loss and selected bone protection; also treats vaginal symptoms	Protects the uterus lining in a suitable systemic estrogen regimen	Treats the actual problem when estrogen isn't right or wanted
What it doesn't do	Doesn't treat whole-body symptoms or protect bones	Doesn't make every symptom hormonal	Isn't FDA-approved as a stand-alone insomnia or depression treatment	"Non-hormonal" isn't one treatment with one effect
Progestogen needed if you have a uterus?	Not with low-dose products (Menopause Society)	Uterine-lining protection is needed, usually a progestogen; some specific approved regimens use an alternative	—	—
Age and timing	No under-60 cutoff for starting; your history still matters (UChicago)	Most favorable under 60 or within 10 years of menopause (Menopause Society)	Follows the estrogen	Depends on the treatment
Ask your clinician	"Which exact cream, tablet or ring — and is it local or systemic?"	"Why systemic, and how will we protect my uterus?"	"What's this progestogen for in my plan?"	"Which option targets my main symptom?"

Two traps to avoid:

• Not every vaginal ring is local. Some rings deliver low-dose local estrogen; at least one delivers systemic estrogen. Ask which one you're getting.
• "Bioidentical" doesn't mean FDA-approved. It describes a hormone's shape. FDA approval applies to a finished medicine, and compounded drugs aren't FDA-approved. FDA-approved estradiol and micronized progesterone both exist. Ask for the exact product name and maker. FDA · Compounded vs FDA-approved HRT

For more detail, see systemic vs local estrogen and do you need progesterone if you have a uterus?

---

Early menopause and removed ovaries: when HRT is advised even without symptoms

For confirmed premature ovarian insufficiency — loss of normal ovarian function before 40 — the international guideline recommends hormone therapy until the usual age of menopause even without symptoms, unless contraindicated. Periods stopping before 40 need evaluation first. Early menopause at ages 40–44, and removal of both ovaries before the usual menopause age, also call for their own hormone discussion. This is about replacing estrogen your body would normally still be making.

A few terms:

• Premature ovarian insufficiency (POI) means the ovaries stop working normally before 40.
• Early menopause is menopause at ages 40–44.
• Surgical menopause happens when both ovaries are removed before natural menopause. Removing only the uterus (a hysterectomy) is different — your ovaries may keep working.

The 2024 guideline from ESHRE, ASRM, IMS and others makes it a strong recommendation: hormone therapy for women with POI "until the usual age of menopause… whether there are estrogen deficiency symptoms or not." Guideline The Menopause Society likewise notes that early or premature menopause carries higher risks of bone loss, heart disease and mood or thinking problems. Source

This is very different from taking HRT "for prevention" after menopause at the usual age. Please don't let anyone blur the two.

Where to start: in person, with an OB-GYN, a reproductive endocrinologist or a menopause specialist. If you're under 40 and your periods have stopped, that change needs evaluation first — it isn't something to self-diagnose. Our own Find My HRT Path tool shows guidance only, with no partner links, for women under 35, and online services set their own age limits. Two more notes: menopause HRT isn't birth control, and women with POI can occasionally still get pregnant — ask about contraception.

(Made-up example.) Maya is 38. Her periods stopped eight months ago. She has no hot flashes and feels mostly fine. "No sweating" doesn't mean nothing needs checking. Her next step is an evaluation of why her periods stopped — not a subscription.

More in online HRT for early menopause, HRT for premature ovarian insufficiency, surgical menopause and HRT after oophorectomy.

---

Should you take HRT just to protect your bones, heart or brain?

For most women who reach menopause at the usual age and feel fine, no. The U.S. Preventive Services Task Force recommends against systemic hormone therapy for routine prevention of chronic conditions in this group. HRT isn't approved to prevent heart disease or dementia. Bone protection is a separate approved use of some products for selected women, with non-estrogen options considered first.

Bones

Preventing postmenopausal osteoporosis is an FDA-approved use of some estrogen products. The labels add a limit: when estrogen is used only for that purpose, it should be considered for women at significant risk, and non-estrogen medicines should be considered first. Label The Menopause Society says that for women under 60 or within 10 years of menopause with no reasons to avoid it, the benefit-risk balance is favorable for preventing bone loss. Source

Practical step: ask your doctor about a fracture-risk assessment and whether a bone density scan makes sense. That answer tells you whether bones are a real reason in your case.

Heart and brain

HRT isn't approved to prevent heart disease or dementia. The February 2026 Enjuvia label says its safety and efficacy for those prevention purposes have not been established; wording varies by product and label version. The USPSTF's recommendation addresses systemic HRT for primary prevention in asymptomatic postmenopausal people — not treatment of symptoms, POI or surgical menopause. Updated label · USPSTF

What about the 2026 FDA headlines?

On February 12, 2026, FDA approved labeling changes for the first six menopausal hormone products that removed boxed-warning statements about heart disease, breast cancer and probable dementia. FDA also said randomized studies show women who start HRT within 10 years of menopause — generally before 60 — have lower all-cause mortality and fewer fractures. FDA

Here's what that did and didn't change:

• It changed the most prominent warning box on updated labels.
• It didn't make HRT an approved heart or dementia prevention drug.
• It didn't change the USPSTF recommendation.
• It didn't make every product's label identical — 29 companies had submitted proposed updates, and approval happens product by product. Updated labels

So if you feel well and are asking, "Am I making a mistake by not taking HRT?" — not automatically. A specific reason, like early menopause or high fracture risk, changes the conversation. General prevention after a usual-age menopause doesn't. More in the 2026 HRT label change, HRT and heart disease and HRT and dementia risk.

---

Your 5-question route check

Five questions help you identify what to discuss and where to start: an in-person assessment, early-menopause evaluation, local-symptom care, assessment of other symptoms, or prevention advice. This isn't a diagnosis, a prescription recommendation or clearance for online treatment.

1. Do any of these apply to you? Unexplained vaginal bleeding; a past blood clot, stroke or heart attack; breast or another estrogen-sensitive cancer; liver disease; a chance you're pregnant. → Yes or not sure: Start with your own clinician or a Menopause Society Certified Practitioner. Stop here for now. → No: Go to question 2.

2. Are you under 45 with periods that have stopped, or were both ovaries removed before the usual menopause age? → Yes: Follow the early-menopause path, in person. → No: Go to question 3.

3. Are vaginal dryness, pain with sex or urinary symptoms your only symptoms? → Yes: Ask whether GSM is the cause and whether low-dose vaginal estrogen or non-hormonal local care fits. Low-dose vaginal estrogen has no automatic age-60 cutoff, but the product and your history still matter. A possible current UTI needs assessment, not waiting for estrogen to work. → No, or not only: Go to question 4.

4. Do night sweats, poor sleep, low mood or achy joints bother you most days? → Yes: Ask a clinician to assess the problem and treatment choices. Systemic HRT has stronger evidence for menopause-related night sweats than for sleep, mood or aches on their own. A monitored trial may fit selected situations after that review. Use the tracker for a treatment you agree on, and see where to get care. → No: Go to question 5. Before starting systemic HRT at 60 or older, or more than 10 years after menopause: get an individualized benefit-risk review. This is not an automatic ban. See can you start HRT after 60? and 10 years after menopause.

5. Do you feel fine and just want prevention? → Yes: Start with your primary care doctor and a bone-risk check. An online symptom service isn't the right first stop. → No, my concern is something else: bring that concern to your clinician for assessment — including brain fog, fatigue, hair changes or low desire. This checklist doesn't rule out care or choose a medicine for you.

If questions 3 or 4 describe you and questions 1 and 2 do not, an online assessment may be useful if the service can address your concern and serve your age and state. Your answers here do not establish that HRT is appropriate or that a provider will accept you.

---

Will a doctor prescribe HRT if you don't have hot flashes?

A clinician can prescribe it when there's an appropriate reason: vaginal or urinary symptoms, early menopause, high bone risk, or bothersome symptoms that fit perimenopause. A clinician may be more cautious when fatigue or brain fog is your only concern, because evidence for those alone is weak and other causes are common. A good visit ends with a clear explanation — yes, no or not yet — and why.

Some doctors focus on hot flashes because the strongest evidence and the main approved uses center on VMS, vaginal symptoms and bone. That's not a reason to give up. It's a reason to be specific.

Please don't report symptoms you don't have to get a prescription. It can steer you to the wrong treatment, and it makes it harder to tell whether anything is working.

If a clinician says HRT is "only for hot flashes," ask what's behind that. Is it the evidence for your symptom? Something in your health history? The clinic's prescribing policy? Insurance? Then ask about alternatives, or get a second opinion. More in how to ask your doctor for HRT.

Copy this appointment note

A short note keeps the visit focused on what matters most to you. Leave anything you're unsure about as "not sure" rather than guessing.

Same search, three different next steps

These made-up examples show how one search can lead to very different conversations. They show what to ask, not what anyone should take.

On a small screen, scroll sideways to see every column.

Made-up example	Useful next conversation	What this page can't decide
Age 53; dryness and painful sex; no hot flashes	Whether symptoms are genitourinary and whether local treatment could handle them	The cause, or which prescription
Age 47; poor sleep and cycle changes; no hot flashes or night sweats	Whether menopause is contributing, other sleep causes, CBT-I, and where HRT fits	Whether a patch will fix her sleep
Age 38; periods have stopped; no hot flashes	An evaluation of why her periods stopped, including possible POI	A POI diagnosis, or a direct route to a commercial HRT plan

---

Where to get HRT without hot flashes

If you're paying cash and want follow-up included, Gala Health is our featured starting point; if you want insurance to pay, start with your own doctor or an insurance-billing service like Midi; if your symptoms are only vaginal, a local pharmacy route with insurance may cost the least. Online care isn't the right first stop for red flags, early menopause or prevention-only questions.

Choose care for the assessment you need, not just for access to hormones. Your current clinician may be the simplest start.

On a small screen, scroll sideways to see every column.

What you're comparing	Gala Health HRT (featured partner)	Midi Health	Alloy	Your own OB-GYN or primary care
Best fit for this reader	Cash-pay, wants assessment of whole-body or vaginal symptoms with advertised follow-up; age/state confirmed by Gala	Wants insurance to cover visits	Wants a published pill/patch price menu	Red flags, early menopause, prevention questions, continuity
Does the published starting screen include non-hot-flash symptoms?	Yes — its HRT landing page offers sleep/fatigue, mood/brain fog, and libido/intimate comfort choices; full intake not tested	Not confirmed	Not confirmed	Discuss your actual concern at the visit
Menopause medicines listed	Estradiol pill or patch, progesterone, vaginal estradiol (cream or vaginal tablet), non-hormonal options	Prescriptions sent to your pharmacy	Estradiol pill, patch, gel, spray; progesterone	Options within the clinician's scope
FDA status of what you'd receive	Gala says it prescribes FDA-approved bioidentical forms; exact product and maker not published	Confirm the exact prescribed product; no dispensed prescription was reviewed	Markets FDA-approved products; confirm what's dispensed	You can ask for a named product
Insurance	Doesn't bill insurance; FSA/HSA accepted	Bills many commercial plans; Medicare self-pay with restrictions on submitting related claims; cannot accept Medicaid/Medi-Cal patients	Doesn't bill insurance	Plan-dependent
Published price	$69/month flat, advertised on its HRT page; no membership fee	Self-pay: $250 first visit, $150 follow-up; medicine separate	$49 one-time consult; three-month supplies: pill from $39.99/mo, patch $100/mo, progesterone from $23/mo	Copay or deductible, plus pharmacy
Speed	Provider review "usually within 1 day"; a short video visit in some states	Scheduled video visits	Online clinician review	Varies
Follow-up	Messaging, symptom check-ins and dose adjustments advertised as included	Visits as booked	Messaging	Visits as booked
States	"Most US states," confirmed in the assessment	All 50 states	Confirm at signup	—
HRT age range	Not published; ask in the assessment	Confirm when registering	Confirm at signup	—

Provider-published information. Gala, Midi and Alloy checked October 14, 2026. Prices and terms change. Unknown costs are not zero, and "included" is only what the provider states.

When Gala is a strong starting point

Gala fits a specific reader well: you're ready for a cash-pay menopause assessment, want a clinician to look at symptoms that aren't hot flashes, and value follow-up built in. Gala must confirm your age, state and medical suitability.

Here's why it suits the no-hot-flash reader in particular, based on what Gala publishes (checked October 14, 2026):

1. Its published HRT starting screen includes your main problem, not just hot flashes. The first question asks what's bothering you most and offers sleep and fatigue, mood and brain fog, and libido and intimate comfort as choices.
2. Both routes are on one menu. Gala lists whole-body estradiol (pill or patch) and vaginal estradiol (cream or vaginal tablet), and its vaginal estradiol page is written for women who want "local relief without systemic HRT." It also lists non-hormonal options if hormones don't fit.
3. Follow-up is part of the plan. Gala advertises provider messaging, symptom check-ins and dose adjustments "for as long as you're treated" — exactly what a tracked trial needs.
4. One flat advertised price. Gala's HRT page advertises $69 a month with no membership fee and "no price rise when your dose changes," with your exact plan and price shown before you pay. FSA and HSA cards are accepted.
5. It's quick. Gala says a provider usually reviews your assessment within a day, with free one-to-two-day shipping. Some states require a short video visit.

One woman's account, chosen and published by Gala on its hormone health page:

"Gala's provider walked me through the options and I started HRT." — Allison, 51, Gala patient

That's one person's description of the process, selected by Gala. It isn't independently verified, and it isn't evidence of results.

The honest tradeoffs:

• No insurance billing. If your plan covers generic vaginal estrogen or estradiol, a pharmacy route may cost less — especially for vaginal-only care.
• Exact medicine not named. Gala says it uses FDA-approved bioidentical forms, but its pages don't name the brand or maker, and its vaginal estradiol page doesn't name a product.
• Price coverage for every combination isn't stated. Gala's vaginal estradiol page doesn't show a price, and we couldn't confirm that $69 covers vaginal estradiol alone, or vaginal plus whole-body treatment.
• Terms need confirming. Gala's linked refund policy (dated February 2026) is written around its weight-loss program, says the first month is charged when you finish intake, and requires at least 72 hours' notice before renewal, and generally rules out refunds on cancellation except for medical disqualification. Its full-refund and remaining-period refund descriptions also differ. Confirm which written terms apply to HRT.
• Some Gala figures aren't sourced. Its "70% of women… in 8 weeks" claims and week-by-week relief timeline aren't backed by a named study. Its vaginal-estradiol page also includes whole-body benefit language that should not be read as evidence that local treatment improves sleep or cognition. Judge medical claims by the trials and guidelines above.
• Not for every reader. Gala isn't the right start for red flags, early menopause or prevention-only questions.

Ask before you pay:

1. "What exact estradiol, progesterone or vaginal product would I get, from which maker — and is it FDA-approved?"
2. "Does $69 cover vaginal estradiol on its own, and whole-body plus vaginal together?"
3. "Are any lab tests required or billed separately?"
4. "Which terms govern this HRT order? When am I charged, when does it renew, and what's the cancellation deadline?"
5. "How do refill reviews, prescription transfers and access to my records work if I leave?"

If you're ready for cash-pay assessment of symptoms other than hot flashes, and want messaging and follow-up built in, Gala is where we'd start — provided it can serve your age and state and confirms the exact treatment, full price and HRT terms. A clinician, not this page, decides whether hormones fit.

Affiliate link. A Gala clinician decides whether treatment is right for you; a prescription isn't guaranteed.

For billing and cancellation details, see our full Gala HRT review, or compare Gala vs Midi and Gala vs Alloy.

When insurance should come first

If insurance matters more than a bundled cash price, check your plan before paying for anything. Visit coverage and medicine coverage are separate questions. There's no universal answer based on hot flashes alone — ask about the exact product, the documented reason for treatment, prior authorization and your out-of-pocket cost.

Midi Health bills many commercial plans for scheduled video visits and serves all 50 states. Medicare beneficiaries may self-pay, but Midi says they cannot submit claims related to Midi visits, medications or associated services. It cannot currently accept Medicaid or Medi-Cal patients. Prescriptions go to your pharmacy; check drug coverage separately, including the Medicare restriction above.

Using your health plan matters more than a cash bundle? Check Midi's insurance and visit pricing (not an affiliate link). Or start with what HRT is covered by insurance.

When you want a named product and a price menu first

Alloy publishes a menu before you start: a $49 consultation, an estradiol pill from $39.99 a month, a patch at $100 a month, and progesterone from $23 a month. It doesn't bill insurance. Even here, confirm the exact product you'll receive. See Alloy's estradiol patch details (not an affiliate link).

The monthly figures are for three-month supplies, and the patch page explicitly says shipped and billed every three months: $300 for that patch supply, before the separate $49 consultation. Shipping is advertised as free. Confirm the total and payment stages for your actual prescription. Patch pricing

Cancellation and continuity: Alloy's terms give two deadlines: cancel a subscription at least seven days before the current period ends, and pause or cancel a shipment at least five business days before it processes. Ask which dates govern your order. Consultation and other service fees are nonrefundable; product refunds are limited to a first shipment, with a request within 30 days of receipt. The terms also allow requesting a prescription transfer to your chosen pharmacy. Terms

For more options, see our full comparison of online HRT providers.

---

What does HRT cost if you don't have hot flashes?

It depends on the route. Vaginal estrogen through insurance can be the cheapest path, while cash-pay whole-body care ranges from a $69 flat advertised monthly plan to menus that charge separately for each medicine. A real total adds the care fee, every medicine you need and any tests, minus what insurance pays — and an unknown cost isn't zero.

First 90 days: subtotals, not verified totals

We used published, regular prices — no promo codes. These compare three advertised Gala charges, three-month Alloy supplies, or an example set of Midi visits. They are not confirmed amounts payable within the same first 90 days, and unknown required costs remain outside the subtotals.

On a small screen, scroll sideways to see every column.

Route	Example path	How we got the number	Illustrative subtotal	Still unknown
Whole-body, with a uterus (estrogen + progesterone)	Gala	3 advertised charges × $69	$207 in advertised plan charges; regimen coverage unconfirmed	Whether $69 covers both medicines and a patch; first-charge timing; labs; exact product
	Alloy — pill + progesterone	$49 + (3 × $39.99) + (3 × $23)	From $237.97	Exact dose/quantity; tests; order-specific payment stages
	Alloy — patch + progesterone	$49 + (3 × $100) + (3 × $23)	From $418	Exact dose/quantity; tests; payment stages (patch billed every 3 months)
	Midi — self-pay	$250 first visit + one $150 follow-up	$400 + medicines + labs	Medicine and lab prices; one follow-up is an example, not a required schedule
Whole-body, after a hysterectomy (estrogen alone)	Gala	3 × $69	$207 in advertised plan charges; prescription total unconfirmed	As above
	Alloy — pill	$49 + (3 × $39.99)	From $168.97	Exact dose/quantity; tests; payment stages
	Alloy — patch	$49 + (3 × $100)	$349	Tests; order-specific payment stages (patch billed every 3 months)
Vaginal estrogen only	Gala	Vaginal-only price not confirmed	Cannot calculate from published details reviewed	Ask whether it is included in $69 and for the exact product, quantity and total
	Your doctor + pharmacy with insurance	Copay + pharmacy	Plan-dependent	Deductible, coverage, product tier

Provider prices: Gala, Midi and Alloy checked October 14, 2026.

Monthly price, billing interval and amount due today aren't the same thing

A "per month" price doesn't tell you how many charges land in your first 90 days. For illustration only: if $69 were billed every 28 days, starting on day 1, you'd see charges on days 1, 29, 57 and 85 — four charges, or $276, in 90 days. That's a hypothetical, not Gala's confirmed schedule.

Gala's amount due today remains unconfirmed for an HRT order. Its February 2026 refund policy says the first month is charged when intake is completed, but the policy is written around weight-loss care. The HRT advertisement says the exact plan and price are shown before payment; that does not settle the governing HRT billing terms. Ask which contract applies before paying. HRT offer · Policy

For Alloy, the table counts the $49 consultation once, then a three-month medicine supply. At the published starting prices, another pill-plus-progesterone supply would be $188.97 ($119.97 + $69), and another patch-plus-progesterone supply would be $369 ($300 + $69), before any additional required costs. Those are medicine subtotals, not guaranteed renewals or the amount due at the first click. Confirm which charges are collected together and what commitment applies before authorizing payment. For Midi, ask when your visit charge is collected and what cancellation, refill and record-transfer terms apply; those details were not established by the pricing page.

What this tells you:

• If you want a patch and pay cash: Gala's three-charge subtotal is $211 less than Alloy's starting patch-plus-progesterone subtotal ($418 − $207) — if $69 covers your patch and progesterone. That's a difference between stated examples, not a verified saving.
• If a pill works for you: the example arithmetic is $207 vs from $237.97, but the Gala bundle and payment timing still need confirming. Compare follow-up, refund terms and the exact product before treating the difference as a saving.
• If your symptoms are only vaginal and you have insurance: check your pharmacy price before paying any cash plan. See the cheapest vaginal estrogen without insurance to compare.

For more, see HRT cost in 2026 and our HRT cost calculator.

---

Are the risks different if you don't have hot flashes?

Not having hot flashes doesn't, by itself, tell you your HRT risk. Risk depends on the product, route, dose, age and health history; the expected benefit depends on the problem being treated. If that benefit is uncertain, even a small risk matters more — but vaginal symptoms, early hormone loss and bone protection have their own benefit-risk discussions.

The broad picture from The Menopause Society's 2022 statement (source):

• Timing: for women under 60 or within 10 years of menopause with no reasons to avoid it, the benefit-risk balance is favorable for treating bothersome vasomotor symptoms and preventing bone loss. Starting later needs a more careful talk.
• Route: estrogen through the skin (patch, gel or spray) and lower doses may carry less risk of blood clots and stroke than pills.
• Your uterus: unopposed systemic estrogen raises uterine-lining cancer risk when you have a uterus, so protection is needed — usually a progestogen in an appropriate regimen. This is not the same rule as for low-dose local vaginal estrogen.
• Your history: unexplained bleeding, past clots, stroke, heart attack, estrogen-sensitive cancers and liver disease change the conversation entirely.

Low-dose vaginal estrogen generally causes much less systemic exposure than systemic HRT, but absorption is not zero and varies by product and dose. That is why its risk discussion is different. Your history still matters. Menopause Society

For more, see HRT benefits and risks and who should not take HRT.

Can stopping HRT give you hot flashes you never had?

Hot flashes or night sweats can be reported after stopping HRT, but the often-quoted WHI figures do not tell you the risk of a new hot flash in someone who has never had one. Researchers surveyed 8,405 women after the estrogen-plus-progestin trial stopped. Moderate or severe vasomotor symptoms — hot flashes or night sweats were reported by 21.2% of former hormone users and 4.8% of placebo users; among women with VMS at randomization, the figures were 55.5% and 21.3%. Most women reporting VMS after stopping had a prior history of them. Respondents averaged 69 years of age and had stopped long-term study pills, so this is not a forecast for a younger woman considering treatment for another reason. Study

The practical point: before you start, ask how and when you'd stop. More in what happens when you stop HRT.

I'm already on HRT and don't have hot flashes. Should I stop?

Not on that basis alone. Hot flashes may not have been the reason you started. Review the original goal, how you're doing, your risks and your next review date with your prescriber, rather than making a change yourself.

---

How to tell if HRT is helping when hot flashes aren't your measure

For a treatment you and your clinician agree on, record the one or two symptoms that matter most before starting, then again at about 4 and 12 weeks or the review dates your clinician sets. If nothing you care about has changed, that's useful information, not a failure. UK guidance suggests review at 3 months and then yearly, with earlier review when needed. NICE NG23

Hot-flash guides count hot flashes. That doesn't help if you never had them. So we built a tracker around the symptoms women without hot flashes actually ask about.

Looking for hot-flash relief without hormones instead?

Treating hot flashes without HRT is the opposite question — and a different decision. There are FDA-approved non-hormonal prescriptions for moderate-to-severe hot flashes, plus off-label options and therapy-based approaches. Start with non-hormonal options for menopause, non-hormonal hot-flash medication online or Veozah vs HRT. If you do have hot flashes and are considering HRT, see HRT for hot flashes.

---

How we researched this page

We checked medical claims against FDA labeling and announcements, The Menopause Society, U.S. and UK guidance, an international POI guideline and peer-reviewed trials, and provider claims against each provider's own pages. This is document-based research and editorial judgment — not firsthand care, patient testing or clinical review — and we label what we couldn't confirm.

For this guide, we applied The HRT Index Verification Standard under its five pillars:

On a small screen, scroll sideways to see every column.

Pillar	What we checked here	Honest limit
Clinical legitimacy	Guideline positions, product labeling, and whether featured services describe licensed clinicians and history review	We didn't verify individual clinicians' licenses
Care quality	Advertised follow-up, messaging, dose adjustment and when in-person care comes first	We didn't receive care; testimonials aren't quality measures
Medication fit	Local vs systemic, uterine-lining protection, FDA-approved vs compounded, approved vs off-label use, evidence for each symptom	Gala's dispensed products remain unconfirmed
Price transparency	Care fees, each medicine, labs, shipping, billing interval, first charge, cancellation and refunds	Checkout totals weren't seen; unknowns aren't counted as zero
Access	States, age limits, insurance, and situations that need different care	Final eligibility is set by each provider; our quiz features a limited set of services

Gala's featured position is a disclosed commercial placement, not a clinical award or proof that it's the best treatment for women without hot flashes. We keep non-paying options on the page when they fit a reader better. Read our methodology and affiliate disclosure.

---

Questions women ask about HRT without hot flashes

Can you take HRT if you don't have hot flashes? Yes, when a clinician identifies an appropriate reason — such as GSM, confirmed early hormone loss or selected bone protection. Sleep, mood and aches need a more specific discussion; a monitored trial may fit some situations. Routine heart or dementia prevention after usual-age menopause is not a reason to start.

Do night sweats count if I never get daytime hot flashes? Yes. Menopause-related night sweats are vasomotor symptoms too. Describe them clearly, and let a clinician consider other causes of sweating.

Can I ask for treatment while I still have periods? Yes. You can ask for help during perimenopause. HRT isn't birth control, so if pregnancy is possible, talk about contraception separately.

Will HRT help brain fog if I don't have hot flashes? HRT isn't an established stand-alone brain-fog treatment. The Helsinki trial did not show a memory/concentration benefit in its group without baseline hot flashes. Ask a clinician to look at sleep, mood, medicines and other causes first.

Is vaginal estrogen the same as HRT? Low-dose vaginal estrogen is a local hormone treatment for vaginal and selected urinary symptoms. It generally produces much less systemic exposure than systemic HRT, but absorption varies by product and dose. It usually doesn't need progesterone and isn't intended to treat whole-body symptoms.

Should I take HRT to prevent osteoporosis? It's an approved use for women at significant risk, but non-estrogen options are usually considered first. Ask about a fracture-risk assessment and bone density scan.

Does HRT protect your heart? HRT isn't approved to prevent heart disease. The updated Enjuvia label says prevention safety and efficacy have not been established. USPSTF recommends against routine systemic HRT for primary prevention in asymptomatic postmenopausal people; that scope excludes POI and surgical menopause.

Do I need a blood test to get HRT without hot flashes? Not automatically. Many otherwise healthy people aged 45 or older with a typical menopause history don't need hormone testing, but no-hot-flash symptoms and period changes still need assessment. Tests may be useful under 45 or when another cause is suspected.

Will insurance cover HRT if I don't have hot flashes? There's no universal answer based on that symptom. Ask about the exact product, the reason for treatment, prior authorization and your out-of-pocket cost.

Will an online HRT service prescribe without hot flashes? Gala's published HRT starting screen includes symptoms other than hot flashes. A clinician still decides whether treatment fits.

I'm 62 with no hot flashes. Should I start HRT? Starting after 60, or more than 10 years after menopause, needs a careful conversation with a clinician, because the benefit-risk balance shifts with age.

Does Gala's $69 plan include vaginal estrogen? Gala lists vaginal estradiol, but its pages don't show a price for it or confirm it's covered by $69. Ask before you pay.

---

What's your next step?

You now know which problems HRT helps strongly without hot flashes, where the evidence is thin, when to start in person, and what care can cost. The last step is choosing where to begin:

• A red flag or a complicated history: start with your own clinician or a Menopause Society Certified Practitioner. Bring the appointment note.
• Under 45 with periods stopped, or both ovaries removed before the usual menopause age: early-menopause care, in person.
• Vaginal or urinary symptoms only: ask about vaginal estrogen through your doctor and insurance, or online.
• You feel fine and want prevention: your primary care doctor and a bone-risk check.
• Bothersome symptoms, paying cash, ready for a clinical assessment: Gala, subject to its age/state access and the treatment review.
• Still not sure where you fit: use the tool below.

You don't need hot flashes to deserve a real answer. Answer five quick questions — what's bothering you most, what you've tried, your age, your state and your health history — and you'll see a featured care option for your situation, or a clear flag if online care isn't the right place to start. It's free, takes about 60 seconds, and doesn't ask for your email.

Already decided on cash-pay care with follow-up included?

Affiliate link.

---

Sources

Medical and regulatory (checked October 14, 2026)

• The North American Menopause Society. The 2022 hormone therapy position statement. Menopause, 2022;29(7):767–794.
• The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement. Menopause, 2020;27(9):976–992.
• ESHRE, ASRM, CRE-WHiRL and IMS Guideline Group on POI. Evidence-based guideline: premature ovarian insufficiency. 2024.
• Maki PM, et al. Guidelines for the evaluation and treatment of perimenopausal depression. Journal of Women's Health and Menopause, 2018.
• National Institute for Health and Care Excellence (UK). Menopause: identification and management (NG23), recommendations 1.5.21 and 1.9. Updated April 15, 2026.
• U.S. Preventive Services Task Force. Hormone therapy in postmenopausal persons: primary prevention of chronic conditions. November 1, 2022.
• U.S. Food and Drug Administration. FDA approves labeling changes to menopausal hormone therapy products. February 12, 2026; Menopausal hormone therapies with updated prescribing information.
• Estradiol transdermal system, Sandoz/Noven. Primary prescribing information, version revised January 2025, retrieved October 14, 2026; sections 1.2 and 1.4. Enjuvia FDA-approved revised label, February 2026, especially indications, endometrial warning, and cardiovascular/dementia prevention statements. Label versions and indications differ.
• U.S. Food and Drug Administration. Understanding the risks of compounded drugs.
• Savolainen-Peltonen H, et al. Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy. Menopause, 2014;21(7):732–739. Primary abstract checked; University of Helsinki bibliographic record. The original 2013 Menopause Society news report is background, not the verification source for the study results.
• Geiger PJ, et al. Effects of perimenopausal transdermal estradiol on self-reported sleep, independent of its effect on vasomotor symptom bother and depressive symptoms. Menopause, 2019;26(11):1318–1323.
• Welton AJ, et al. Health related quality of life after combined hormone replacement therapy: randomised controlled trial (WISDOM). BMJ, 2008;337:a1190.
• Chlebowski RT, et al. Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial. Menopause, 2013;20(6):600–608.
• Ockene JK, et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA, 2005;294(2):183–193.
• Avis NE, et al. Duration of menopausal vasomotor symptoms over the menopause transition (SWAN). JAMA Internal Medicine, 2015.
• National Heart, Lung, and Blood Institute. Insomnia: treatment.
• UChicago Medicine. Can hormone therapy help menopause symptoms? May 2, 2023.
• AUA/SUFU/AUGS. Genitourinary Syndrome of Menopause guideline, 2025. Official guidance for separate urgency/overactive-bladder and recurrent-UTI questions; link to the original resource.
• Davis SR, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism, 2019;104(10):4660–4666.
• U.S. Drug Enforcement Administration. Anabolic Steroids fact sheet. October 2025; control status checked October 14, 2026.

Provider information (provider-published; not quotes)

• Gala Health — Hormone health, HRT offer page, Vaginal estradiol, Symptoms, Refund policy (dated February 2026). Checked October 14, 2026.
• Midi Health — Pricing and insurance. Checked October 14, 2026.
• Alloy — Estradiol patch, estradiol pill, progesterone. Terms of use (revised May 28, 2026). Checked October 14, 2026. Three-month supply and patch billing interval distinguished from order-specific checkout amounts.
• The HRT Index — How Find My HRT Path works.

This article is educational and isn't medical advice. Talk to a licensed clinician before starting, stopping or changing hormone therapy. The HRT Index isn't a healthcare provider, pharmacy or telehealth service. We may earn a commission from labeled partner links; this affects which providers we feature, not the medical information on this page.